Works by Mathijssen, Ron H. J.

Results: 117

Improving the tolerability of osimertinib by identifying its toxic limit.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221103212

By:

Agema, Bram C.;
Veerman, G. D. Marijn;
Steendam, Christi M. J.;
Lanser, Daan A. C.;
Preijers, Tim;
van der Leest, Cor;
Koch, Birgit C. P.;
Dingemans, Anne-Marie C.;
Mathijssen, Ron H. J.;
Koolen, Stijn L. W.

Publication type:

Article

Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221081075

By:

Buck, Stefan A. J.;
Braal, C. Louwrens;
Hofman, Maaike M.;
Oomen-de Hoop, Esther;
Bruijn, Peter de;
Ghobadi Moghaddam-Helmantel, Inge M.;
Hussaarts, Koen G. A. M.;
Vastbinder, Mijntje B.;
van Rossum-Schornagel, Quirine C.;
van Schaik, Ron H. N.;
Jager, Agnes;
Koolen, Stijn L. W.;
Mathijssen, Ron H. J.

Publication type:

Article

Levels of circulating tumor DNA correlate with tumor volume in gastro‐intestinal stromal tumors: an exploratory long‐term follow‐up study.

Published in:

Molecular Oncology, 2024, v. 18, n. 11, p. 2658, doi. 10.1002/1878-0261.13644

By:

Bleckman, Roos F.;
Haag, Charlotte M. S. C.;
Rifaela, Naomi;
Beukema, Gerrieke;
Mathijssen, Ron H. J.;
Steeghs, Neeltje;
Gelderblom, Hans;
Desar, Ingrid M. E.;
Cleven, Arjen;
ter Elst, Arja;
Schuuring, Ed;
Reyners, Anna K. L.

Publication type:

Article

mFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer.

Published in:

Molecular Oncology, 2023, v. 17, n. 9, p. 1898, doi. 10.1002/1878-0261.13449

By:

Isebia, Khrystany T.;
Mostert, Bianca;
Deger, Teoman;
Kraan, Jaco;
de Weerd, Vanja;
Oomen‐de Hoop, Esther;
Hamberg, Paul;
Haberkorn, Brigitte C. M.;
Helgason, Helgi H.;
de Wit, Ronald;
Mathijssen, Ron H. J.;
Lolkema, Martijn P.;
Wilting, Saskia M.;
van Riet, Job;
Martens, John W. M.

Publication type:

Article

AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel.

Published in:

Molecular Oncology, 2019, v. 13, n. 8, p. 1795, doi. 10.1002/1878-0261.12529

By:

Sieuwerts, Anieta M.;
Onstenk, Wendy;
Kraan, Jaco;
Beaufort, Corine M.;
Van, Mai;
De Laere, Bram;
Dirix, Luc Y.;
Hamberg, Paul;
Beeker, Aart;
Meulenbeld, Hielke J.;
Creemers, Geert‐Jan;
Weerden, Wytske M.;
Jenster, Guido W.;
Nieuweboer, Annemieke J. M.;
Mathijssen, Ron H. J.;
Wit, Ronald;
Martens, John W. M.;
Sleijfer, Stefan

Publication type:

Article

The added value of H<sub>2</sub> antagonists in premedication regimens during paclitaxel treatment.

Published in:

2021

By:

Cox, Juul M.;
van Doorn, Leni;
Malmberg, Ruben;
Oomen-de Hoop, Esther;
Bosch, Tessa M.;
van den Bemt, Patricia M. L. A.;
Boere, Ingrid A.;
Jager, Agnes;
Mathijssen, Ron H. J.;
van Leeuwen, Roelof W. F.

Publication type:

journal article

Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer.

Published in:

British Journal of Cancer, 2020, v. 123, n. 12, p. 1715, doi. 10.1038/s41416-020-01105-y

By:

Mout, Lisanne;
Moll, Jan M.;
Chen, Mingqing;
de Morrée, Eleonora S.;
de Ridder, Corrina M. A.;
Gibson, Alice;
Stuurman, Debra;
Aghai, Ashraf;
Erkens-Schulze, Sigrun;
Mathijssen, Ron H. J.;
Sparreboom, Alex;
de Wit, Ronald;
Lolkema, Martijn P.;
van Weerden, Wytske M.

Publication type:

Article

Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer.

Published in:

2020

By:

Mout, Lisanne;
Moll, Jan M.;
Chen, Mingqing;
de Morrée, Eleonora S.;
de Ridder, Corrina M. A.;
Gibson, Alice;
Stuurman, Debra;
Aghai, Ashraf;
Erkens-Schulze, Sigrun;
Mathijssen, Ron H. J.;
Sparreboom, Alex;
de Wit, Ronald;
Lolkema, Martijn P.;
van Weerden, Wytske M.

Publication type:

journal article

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.

Published in:

2018

By:

Bins, Sander;
Basak, Edwin A.;
el Bouazzaoui, Samira;
Koolen, Stijn L. W.;
Oomen - de Hoop, E.;
van der Leest, Cor H.;
van der Veldt, Astrid A. M.;
Sleijfer, Stefan;
Debets, Reno;
van Schaik, Ron H. N.;
Aerts, Joachim G. J. V.;
Mathijssen, Ron H. J.

Publication type:

journal article

Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 504, doi. 10.1002/cpt.3368

By:

Guchelaar, Niels A. D.;
van der Kleij, Maud B. A.;
Steeghs, Neeltje;
Huitema, Alwin D. R.;
Mathijssen, Ron H. J.;
Koolen, Stijn L. W.

Publication type:

Article

Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1162, doi. 10.1002/cpt.3190

By:

Karas, Spinel;
Mathijssen, Ron H. J.;
van Schaik, Ron H. N.;
Forrest, Alan;
Wiltshire, Tim;
Bies, Robert R.;
Innocenti, Federico

Publication type:

Article

Response to "Plasma Uracil as a DPD Phenotyping Test: Pre‐analytical Handling Matters".

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 3, p. 473, doi. 10.1002/cpt.2775

By:

de With, Mirjam;
Knikman, Jonathan;
Schellens, Jan H. M.;
Gelderblom, Hans;
Cats, Annemieke;
Guchelaar, Henk‐Jan;
Mathijssen, Ron H. J.;
Swen, Jesse J.;
Meulendijks, Didier

Publication type:

Article

Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Advanced Cancer Patients: Influence of Demographic and Clinical Factors.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 2, p. 316, doi. 10.1002/cpt.2621

By:

Karas, Spinel;
Mathijssen, Ron H. J.;
van Schaik, Ron H. N.;
Forrest, Alan;
Wiltshire, Tim;
Innocenti, Federico;
Bies, Robert R.

Publication type:

Article

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 1, p. 62, doi. 10.1002/cpt.2608

By:

de With, Mirjam;
Knikman, Jonathan;
de Man, Femke M.;
Lunenburg, Carin A. T. C.;
Henricks, Linda M.;
van Kuilenburg, André B. P.;
Maring, Jan G.;
van Staveren, Maurice C.;
de Vries, Niels;
Rosing, Hilde;
Beijnen, Jos H.;
Pluim, Dick;
Modak, Anil;
Imholz, Alex L. T.;
van Schaik, Ron H. N.;
Schellens, Jan H. M.;
Gelderblom, Hans;
Cats, Annemieke;
Guchelaar, Henk‐Jan;
Mathijssen, Ron H. J.

Publication type:

Article

Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 455, doi. 10.1002/cpt.2444

By:

van Doorn, Leni;
Heersche, Niels;
de Man, Femke M.;
de Bruijn, Peter;
Bijl, Ivo;
Oomen‐de Hoop, Esther;
Eskens, Ferry A. L. M.;
van der Gaast, Ate;
Mathijssen, Ron H. J.;
Bins, Sander

Publication type:

Article

Taste, smell and mouthfeel disturbances in patients with gastrointestinal stromal tumors treated with tyrosine-kinase inhibitors.

Published in:

Supportive Care in Cancer, 2022, v. 30, n. 3, p. 2307, doi. 10.1007/s00520-021-06658-z

By:

van Elst, Jip M.;
IJzerman, Nikki S.;
Mathijssen, Ron H. J.;
Steeghs, Neeltje;
Reyners, Anna K. L.;
de Haan, Jacco J.

Publication type:

Article

Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 1, p. 33, doi. 10.1007/s00280-022-04489-1

By:

de Rouw, Nikki;
Boosman, René J.;
Burgers, Jacobus A.;
Huitema, Alwin D. R.;
Dingemans, Anne-Marie C.;
Derijks, Hieronymus. J.;
Burger, David M.;
Piet, Berber;
Hendriks, Lizza E. L.;
Biesma, Bonne;
Pruis, Melinda A.;
Dumoulin, Daphne W.;
Croes, Sander;
Mathijssen, Ron H. J.;
van den Heuvel, Michel M.;
ter Heine, Rob

Publication type:

Article

Flat-Fixed Dosing Versus Body Surface Area-Based Dosing of Anticancer Drugs in Adults: Does It Make a Difference?

Published in:

Oncologist, 2007, v. 12, n. 8, p. 913, doi. 10.1634/theoncologist.12-8-913

By:

Mathijssen, Ron H. J.;
De Jong, Floris A.;
Loos, Walter J.;
Van Der Bol, Jessica M.;
Verweij, Jaap;
Sparreboom, Alex

Publication type:

Article

Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel.

Published in:

Oncologist, 2007, v. 12, n. 3, p. 291, doi. 10.1634/theoncologist.12-3-291

By:

Engels, Frederike K.;
De Jong, Floris A.;
Sparreboom, Alex;
Mathot, Ron A. A.;
Loos, Walter J.;
Kitzen, Jos J. E. M.;
De Bruijn, Peter;
Verweij, Jaap;
Mathijssen, Ron H. J.

Publication type:

Article

Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for UGT1A1*28 Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study.

Published in:

Oncologist, 2006, v. 11, n. 8, p. 944, doi. 10.1634/theoncologist.11-8-944

By:

DE JONG, FLORIS A.;
KEHRER, DIEDERIK F. S.;
MATHIJSSEN, RON H. J.;
CREEMERS, GEERT-JAN;
DE BRUIJN, PETER;
VAN SCHAIK, RON H. N.;
PLANTING, ANDRÉ S. TH.;
VAN DER GAAST, ATE;
ESKENS, FERRY A. L. M.;
JANSSEN, JOS TH. P.;
RUIT, JAN B.;
VERWEIJ, JAAP;
SPARREBOOM, ALEX;
DE JONGE, MAJA J. A.

Publication type:

Article

A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities.

Published in:

Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091933

By:

Li, Yang;
Jin, Yan;
Taheri, Hanieh;
Schmidt, Keith T.;
Gibson, Alice A.;
Buck, Stefan A. J.;
Eisenmann, Eric D.;
Mathijssen, Ron H. J.;
Figg, William D.;
Baker, Sharyn D.;
Sparreboom, Alex;
Hu, Shuiying

Publication type:

Article

Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib.

Published in:

Pharmaceutics, 2020, v. 12, n. 9, p. 788, doi. 10.3390/pharmaceutics12090788

By:

Hussaarts, Koen G. A. M.;
van Doorn, Leni;
Eechoute, Karel;
Damman, Jeffrey;
Fu, Qiang;
van Doorn, Nadia;
Eisenmann, Eric D.;
Gibson, Alice A.;
Oomen-de Hoop, Esther;
de Bruijn, Peter;
Baker, Sharyn D.;
Koolen, Stijn L. W.;
van Gelder, Teun;
van Leeuwen, Roelof W. F.;
Mathijssen, Ron H. J.;
Sparreboom, Alex;
Bins, Sander

Publication type:

Article

Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase Inhibitors.

Published in:

Pharmaceuticals (14248247), 2021, v. 14, n. 2, p. 119, doi. 10.3390/ph14020119

By:

van Eerden, Ruben A. G.;
Oomen-de Hoop, Esther;
Noordam, Aad;
Mathijssen, Ron H. J.;
Koolen, Stijn L. W.;
Ciccolini, Joseph

Publication type:

Article

The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients.

Published in:

Pharmaceuticals (14248247), 2021, v. 14, n. 1, p. 47, doi. 10.3390/ph14010047

By:

van Doorn, Leni;
Crombag, Marie-Rose B. S.;
Rier, Hánah N.;
van Vugt, Jeroen L. A.;
van Kesteren, Charlotte;
Bins, Sander;
Mathijssen, Ron H. J.;
Levin, Mark-David;
Koolen, Stijn L. W.

Publication type:

Article

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma.

Published in:

Pharmaceuticals (14248247), 2021, v. 14, n. 1, p. 46, doi. 10.3390/ph14010046

By:

Hussaarts, Koen G. A. M.;
van Doorn, Leni;
Bins, Sander;
Sprengers, Dave;
de Bruijn, Peter;
van Leeuwen, Roelof W. F.;
Koolen, Stijn L. W.;
van Gelder, Teun;
Mathijssen, Ron H. J.

Publication type:

Article

The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer.

Published in:

2020

By:

Belderbos, Bodine P. S.;
de With, Mirjam;
Singh, Rajbir K.;
Agema, Bram C.;
El Bouazzaoui, Samira;
Oomen-de Hoop, Esther;
de Wit, Ronald;
van Schaik, Ron H. N.;
Mathijssen, Ron H. J.;
Bins, Sander

Publication type:

journal article

A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function.

Published in:

2016

By:

Azaro, Analía;
Rodón, Jordi;
Machiels, Jean-Pascal;
Rottey, Sylvie;
Damian, Silvia;
Baird, Richard;
Garcia-Corbacho, Javier;
Mathijssen, Ron;
Clot, Pierre-François;
Wack, Claudine;
Shen, Liji;
Jonge, Maja;
Azaro, Analía;
Rodón, Jordi;
Mathijssen, Ron H J;
Clot, Pierre-François;
de Jonge, Maja J A

Publication type:

journal article

Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 Patients.

Published in:

Drugs & Aging, 2024, v. 41, n. 2, p. 165, doi. 10.1007/s40266-023-01084-8

By:

Bleckman, Roos F.;
Broekman, K. Esther;
Roets, Evelyne;
Mohammadi, Mohammed;
Desar, Ingrid M. E.;
Gelderblom, Hans;
Mathijssen, Ron H. J.;
Steeghs, Neeltje;
de Graeff, Pauline;
Reyners, Anna K. L.

Publication type:

Article

Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants.

Published in:

Genes, 2018, v. 9, n. 12, p. 585, doi. 10.3390/genes9120585

By:

Lunenburg, Carin A. T. C.;
Henricks, Linda M.;
van Kuilenburg, André B. P.;
Mathijssen, Ron H. J.;
Schellens, Jan H. M.;
Gelderblom, Hans;
Guchelaar, Henk-Jan;
Swen, Jesse J.

Publication type:

Article

Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.

Published in:

Targeted Oncology, 2024, v. 19, n. 5, p. 789, doi. 10.1007/s11523-024-01075-8

By:

Moes, Dirk J. A. R.;
Hendrikx, Jeroen J. M. A.;
Guchelaar, Henk-Jan;
Mathijssen, Ron H. J.;
Bakker, J. L.;
Dezentjé, Vincent O.;
de Rouw, Nikki;
van Erp, Nielka P.;
Smit, Egbert F.;
van den Heuvel, Michel M.;
Munnink, Thijs H. Oude;
van Kats, Maartje;
Croes, Sander;
Kroep, Judith R.;
Zwaveling, Juliette;
ter Heine, Rob

Publication type:

Article

CBD-oil as a potential solution in case of severe tamoxifen-related side effects.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00570-x

By:

Buijs, Sanne M.;
Braal, C. Louwrens;
Buck, Stefan A. J.;
van Maanen, Noud F.;
van der Meijden-Erkelens, Lonneke M.;
Kuijper-Tissot van Patot, Heleen A.;
Hoop, Esther Oomen-de;
Saes, Lotte;
van den Boogerd, Sophia J.;
Struik, Liesbeth E. M.;
van Rossum-Schornagel, Quirine C.;
Mathijssen, Ron H. J.;
Koolen, Stijn L. W.;
Jager, Agnes

Publication type:

Article

Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen.

Published in:

Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00283

By:

Klopp-Schulze, Lena;
Mueller-Schoell, Anna;
Neven, Patrick;
Koolen, Stijn L. W.;
Mathijssen, Ron H. J.;
Joerger, Markus;
Kloft, Charlotte

Publication type:

Article

CYP3A4<sup>∗</sup>22 Genotyping in Clinical Practice: Ready for Implementation?

Published in:

Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.711943

By:

Mulder, Tessa A. M.;
van Eerden, Ruben A. G.;
de With, Mirjam;
Elens, Laure;
Hesselink, Dennis A.;
Matic, Maja;
Bins, Sander;
Mathijssen, Ron H. J.;
van Schaik, Ron H. N.

Publication type:

Article

Hyperhydration with cisplatin does not influence pemetrexed exposure.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 2, p. 871, doi. 10.1111/bcp.15031

By:

de Rouw, Nikki;
Derijks, Hieronymus J.;
Hilbrands, Luuk B.;
Boosman, René J.;
Piet, Berber;
Koolen, Stijn L. W.;
Burgers, Jacobus A.;
Dingemans, Anne‐Marie C.;
van den Heuvel, Michel M.;
Hendriks, Lizza E. L.;
Aerts, Joachim G. J. V.;
Croes, Sander;
Mathijssen, Ron H. J.;
Huitema, Alwin D. R.;
Burger, David M.;
Biesma, Bonne;
ter Heine, Rob

Publication type:

Article

A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 2, p. 294, doi. 10.1111/bcp.13129

By:

Kuip, Evelien J. M.;
Zandvliet, Maarten L.;
Koolen, Stijn L. W.;
Mathijssen, Ron H. J.;
Rijt, Carin C. D.

Publication type:

Article

4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes.

Published in:

British Journal of Clinical Pharmacology, 2015, v. 80, n. 3, p. 560, doi. 10.1111/bcp.12707

By:

Graan, Anne‐Joy M.;
Sparreboom, Alex;
Bruijn, Peter;
Jonge, Evert;
Holt, Bronno;
Wiemer, Erik A. C.;
Verweij, Jaap;
Mathijssen, Ron H. J.;
Schaik, Ron H. N.

Publication type:

Article

Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662.

Published in:

British Journal of Clinical Pharmacology, 2015, v. 79, n. 5, p. 809, doi. 10.1111/bcp.12550

By:

Yu, Huixin;
Steeghs, Neeltje;
Kloth, Jacqueline S. L.;
Wit, Djoeke;
Hasselt, J. G. Coen;
Erp, Nielka P.;
Beijnen, Jos H.;
Schellens, Jan H. M.;
Mathijssen, Ron H. J.;
Huitema, Alwin D. R.

Publication type:

Article

Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen.

Published in:

British Journal of Clinical Pharmacology, 2014, v. 78, n. 3, p. 572, doi. 10.1111/bcp.12388

By:

Heine, Rob;
Binkhorst, Lisette;
Graan, Anne Joy M.;
Bruijn, Peter;
Beijnen, Jos H.;
Mathijssen, Ron H. J.;
Huitema, Alwin D. R.

Publication type:

Article

Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice.

Published in:

2016

By:

Huisman, Sander A;
Bruijn, Peter;
Ghobadi Moghaddam ‐ Helmantel, Inge M;
IJzermans, Jan N M;
Wiemer, Erik A C;
Mathijssen, Ron H J;
Bruin, Ron W F;
de Bruijn, Peter;
Ghobadi Moghaddam-Helmantel, Inge M;
de Bruin, Ron W F

Publication type:

journal article

Clinically relevant drug interactions with multikinase inhibitors: a review.

Published in:

Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835918818347

By:

Hussaarts, Koen G. A. M.;
Veerman, G. D. Marijn;
Jansman, Frank G. A.;
van Gelder, Teun;
Mathijssen, Ron H. J.;
van Leeuwen, Roelof W. F.

Publication type:

Article

Clinically relevant drug interactions with multikinase inhibitors: a review.

Published in:

Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835918818347

By:

Hussaarts, Koen G. A. M.;
Veerman, G. D. Marijn;
Jansman, Frank G. A.;
van Gelder, Teun;
Mathijssen, Ron H. J.;
van Leeuwen, Roelof W. F.

Publication type:

Article

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors.

Published in:

Pharmaceutical Research, 2020, v. 37, n. 1, p. 1, doi. 10.1007/s11095-019-2746-9

By:

Hussaarts, Koen G. A. M.;
Berger, Florine A.;
Binkhorst, Lisette;
Oomen - de Hoop, Esther;
van Leeuwen, Roelof W. F.;
van Alphen, Robbert J.;
Mathijssen - van Stein, Daniëlle;
de Groot, Natasja M. S.;
Mathijssen, Ron H. J.;
van Gelder, Teun

Publication type:

Article

Does Older Age Lead to Higher Risk for Neutropenia in Patients Treated with Paclitaxel?

Published in:

Pharmaceutical Research, 2019, v. 36, n. 12, p. N.PAG, doi. 10.1007/s11095-019-2697-1

By:

Crombag, Marie-Rose B. S.;
Koolen, Stijn L. W.;
Wijngaard, Sophie;
Joerger, Markus;
Dorlo, Thomas P. C.;
van Erp, Nielka P.;
Mathijssen, Ron H. J.;
Beijnen, Jos H.;
Huitema, Alwin D. R.

Publication type:

Article

Impact of Older Age on the Exposure of Paclitaxel: a Population Pharmacokinetic Study.

Published in:

Pharmaceutical Research, 2019, v. 36, n. 2, p. 1, doi. 10.1007/s11095-018-2563-6

By:

Crombag, Marie-Rose B. S.;
de Vries Schultink, Aurelia H. M.;
Koolen, Stijn L.W.;
Wijngaard, Sophie;
Joerger, Markus;
Schellens, Jan H. M.;
Dorlo, Thomas P. C.;
van Erp, Nielka P.;
Mathijssen, Ron H. J.;
Beijnen, Jos H.;
Huitema, Alwin D. R.

Publication type:

Article

Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk?

Published in:

2021

By:

van Dorst, Daan C. H.;
van Doorn, Leni;
Colafella, Katrina M. Mirabito;
Manintveld, Olivier C.;
Hassing, H. Carlijne Hassing;
Danser, A. H. Jan;
Mathijssen, Ron H. J.;
Versmissen, Jorie

Publication type:

Literature Review

miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway.

Published in:

Molecular Cancer, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12943-015-0464-4

By:

van Jaarsveld, Marijn T. M.;
van Kuijk, Patricia F.;
Boersma, Antonius W. M.;
Helleman, Jozien;
van IJcken, Wilfred F.;
Mathijssen, Ron H. J.;
Pothof, Joris;
Berns, Els M. J. J.;
Verweij, Jaap;
Wiemer, Erik A. C.

Publication type:

Article

Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 9, p. 1309, doi. 10.1007/s00228-019-02704-2

By:

Groenland, Stefanie L.;
Mathijssen, Ron H. J.;
Beijnen, Jos H.;
Huitema, Alwin D. R.;
Steeghs, Neeltje

Publication type:

Article

Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor-Induced Blood Pressure Rise: A Clinical Cohort Study.

Published in:

Journal of the American Heart Association, 2023, v. 12, n. 1, p. 1, doi. 10.1161/JAHA.122.028050

By:

van Dorst, Daan C. H.;
Kabadayi, Sumeyye;
Hoop, Esther Oomen-de;
Jan Danser, A. H.;
Mathijssen, Ron H. J.;
Versmissen, Jorie

Publication type:

Article

Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer.

Published in:

Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.759146

By:

van Eerden, Ruben A. G.;
van Doorn, Leni;
de Man, Femke M.;
Heersche, Niels;
Doukas, Michail;
van den Bosch, Thierry P. P.;
Oomen-de Hoop, Esther;
de Bruijn, Peter;
Bins, Sander;
Ibrahim, Eman;
Nikkessen, Suzan;
Friberg, Lena E.;
Koolen, Stijn L. W.;
Spaander, Manon C. W.;
Mathijssen, Ron H. J.

Publication type:

Article

Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling.

Published in:

Clinical Pharmacokinetics, 2024, v. 63, n. 10, p. 1449, doi. 10.1007/s40262-024-01425-9

By:

Agema, Bram C.;
Kocher, Tolra;
Öztürk, Ayşenur B.;
Giraud, Eline L.;
van Erp, Nielka P.;
de Winter, Brenda C. M.;
Mathijssen, Ron H. J.;
Koolen, Stijn L. W.;
Koch, Birgit C. P.;
Sassen, Sebastiaan D. T.

Publication type:

Article